medigraphic.com
ISSN 1729-519X (Print)

2021, Number 6

<< Back Next >>

Revista Habanera de Ciencias Médicas 2021; 20 (6)

Reproducibilidad de pruebas de diagnóstico rápido de la infección por Trypanosoma cruzi en áreas endémicas de Colombia

Rojas-Gulloso AC, Montenegro LD, González-Zapata A, Sánchez-Lerma L, Suarez-Izquierdo W, Pacheco S, Fragozo PJ, Omeñaca C

Language: English
References: 38
Page: 1-8
PDF size: 544.12 Kb.


ABSTRACT

Introduction: Chagas disease is a neglected tropical disease of interest to public health because of its social and economic burden. Identifying infected and sick people with Chagas disease constitutes the first step towards achieving World Health Ooganization’s goals for 2020.
Objective: To evaluate the reproducibility with gold standard of a rapid diagnostic test for detection of antibodies to T. cruzi; and to propose a diagnostic algorithm for Chagas disease under the point-of-care concept in an area with limited access to health care coverage.
Material and Methods: A cross-sectional study was performed to detect antibodies to T. cruzi in 151 indigenous volunteers belonging to three ethnic groups of the Sierra Nevada de Santa Marta, Colombia. Rapid tests-PDR SD BIOLINE Chagas Ab were implemented in the field versus confirmation in the laboratory using two standardized serological methods (ELISAs).
Results: The results show that 19,2 % seroreactivity for T. cruzi was found among the entire population screening. The highest rate of human infection with T. cruzi was detected in the Wiwa community. No significant differences between rapid diagnostic test and the standard techniques (ELISAs) were found. Sensitivity, specificity and concordance for RDT were 100 % (Kappa: 1,0).
Conclusions: The Sierra Nevada de Santa Marta continues to be a hyperendemic area for Chagas disease. The area is difficult to access and has low or no primary health care coverage, making the assessed rapid diagnostic test a useful tool for screening programs and defining treatment and control plans, which represents the first approach at establishing a point-ofcare testing strategy for endemic countries for Chagas disease.


REFERENCES

  1. Chagas C. Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n.gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Memórias do Instituto Oswaldo Cruz [Internet].1909[Cited 01/11/2020];1(2):159-218. Available from: https://cutt.ly/VftKSqP

  2. Pérez Molina JA, Molina I. Chagas disease. Lancet [Internet]. 2018 [Cited 03/11/2019];391(10115):82-94. Availablefrom: https://cutt.ly/TftLrQw

  3. World Health Organization. Neglected tropical diseases [Internet]. Geneva: WHO; 2017 [Cited 01/11/2020]. Availablefrom: https://www.who.int/neglected_diseases/diseases/en/

  4. Filigheddu M, Górgolas M, Ramos J. Enfermedad de Chagas de transmisión oral. Medicina Clínica [Internet]. 2017[Cited 11/11/2020];148(3):125-31. Available from: https://cutt.ly/ZzzVceU

  5. Carlier Y, Altcheh J, Angheben A, Freilij H, Luquetti AO, Schijman AG, et al. Enfermedad congénita de Chagas:Recomendaciones actualizadas para la prevención, diagnóstico, tratamiento y seguimiento de recién nacidosy hermanos, niñas, mujeres en edad fértil y mujeres embarazadas. PLoS Negl Trop Dis [Internet]. 2019 [Cited11/11/2020];13(10):e0007694. Available from: https://cutt.ly/vzxpkoh

  6. Rojo J, Ruiz C, Salazar P. Enfermedad de Chagas en México. Gaceta Médica de México [Internet]. 2018 [Cited18/11/2020];154(5):605-12. Available from: https://pubmed.ncbi.nlm.nih.gov/30407465/

  7. World Health Organization. Sustaining the drive to overcome the global impact of neglected tropical diseases.Second WHO report on neglected tropical diseases [Internet]. Geneva: WHO; 2013 [Cited 21/11/2020]. Available from:https://cutt.ly/Pfuy4OX

  8. Tarleton R, Gürtler R, Urbina J, Ramsey J, Viotti R. Chagas Disease and the London Declaration on Neglected Tropical Diseases.PLoS Neglected Tropical Diseases [Internet]. 2014 [Cited 21/11/2020];8(10):e3219 . Available from: https://cutt.ly/kfuyYvv

  9. Pereira M, Bolger A, Marin J. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: AScientific Statement From the American Heart Association. AHA journal [Internet]. 2018 [Cited 01/12/2020];138(12):169-209. Available from: https://cutt.ly/ffuuq6O

  10. World Health Organization. Weekly epidemiological record = Relevé épidémiologique hebdomadaire. WeeklyEpidemiological Record [Internet]. 2015 [Cited 16/10/2021];6(90):33-44. 2015. Available from: https://cutt.ly/TfuutzH

  11. Mejia A, Agudelo L, Dib J, Ortiz S, Solari A, Triana O. Genotyping of Trypanosoma cruzi in a hyper-endemic area ofColombia reveals an overlap among domestic and sylvatic cycles of Chagas disease. Parasites Vectors [Internet]. 2014[Cited 16/10/2021];7:108. Available from: https://cutt.ly/eRpFIvm

  12. Cucunuba Z, Manne J, Diaz D, Nouvellet P, Bernal O, Marchiol A, et al. How universal is coverage and access todiagnosis and treatment for Chagas disease in Colombia? A health systems analysis. Social Science Medicine [Internet].2017 [Cited 02/12/2020];175:187-98. Available from: https://cutt.ly/Kfuuua6

  13. Organización Panamericana de la Salud. Enfermedad de Chagas en las comunidades indígenas De La Sierra Nevadade Santa Marta [Internet]. Washington: Organización Panamericana de la Salud; 2011 [Cited 13/12/2020]. Availablefrom: https://cutt.ly/4fuupDA

  14. Olivera M, Villamil J, Gahona C, Hernández J. Barriers to diagnosis access for chagas disease in Colombia. JournalParasitology Research [Internet]. 2018 [Cited 13/12/2020]:594796. Available from: https://cutt.ly/hfuuIh3

  15. Angheben A, Staffolani S, Anselmi M, Tais S, Degani M, Gobbi F, et al. Accuracy of a Rapid Diagnostic Test (CypressChagas Quick Test® ) for the Diagnosis of Chronic Chagas Disease in a Nonendemic Area: A Retrospective LongitudinalStudy. Am J Trop Med Hyg [Internet]. 2017 [Cited 11/12/2020]; 97(5):1486-8. Available from: https://cutt.ly/wzxKesF

  16. Olivera M, Chaverra K. New Diagnostic Algorithm for Chagas Disease: Impact on Access to Diagnosis and Outof-Pocket Expenditures in Colombia. Iran Journal Public Health [Internet]. 2019 [Cited 05/12/2020];48(7):1379-81.Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708550/

  17. Florez A, Caicedo R. Guía para la vigilancia por laboratorio del Trypanosoma cruzi [Internet]. Colombia: InstitutoNacional de Salud; 2017 [Cited 22/12/2020]. Available from: https://cutt.ly/bfuuXHJ

  18. World Health Organization. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. WeeklyEpidemiological Record. [Internet]. 2015 [Cited 22/12/2020];90( 06):33-44. Available from: https://cutt.ly/Rfuu15p

  19. Castellanos Y, Cucunubá Z, Flórez A, Orozco L. Reproducibilidad de pruebas serológicas para el diagnóstico deinfección por Trypanosoma cruzi en mujeres embarazadas de una zona endémica de Santander, Colombia. Biomédica[Internet]. 2014 [Cited 16/12/2020];34(2):198-206. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/1571

  20. Parra Henao G, Oliveros H, Hotez PJ, Motoa G, Franco Paredes C, Henao Martínez AF. In Search of CongenitalChagas Disease in the Sierra Nevada de Santa Marta, Colombia. Am J Trop Med Hyg [Internet]. 2019 [Cited23/12/2020];101(3):482-3. Available from: https://cutt.ly/hzx68Ew

  21. Valencia C, Caicedo A, Escribano D, Quintero H, Dib J. Programa piloto de control de la enfermedad de Chagasen comunidades indígenas de la Sierra Nevada de Santa Marta, Colombia. Biomédica [Internet]. 2015 [Cited15/12/2020];35(4):180. Available from: https://cutt.ly/vfuifsv

  22. Winner-Lab. Chagas ELISA Lisado. Ensayo inmunoenzimático (ELISA) para la detección de anticuerpos anti-Trypanosomacruzi [Internet]. Argentina: Winner-Lab; 2000 [Cited 15/12/2020]. Available from: https://cutt.ly/MfuiNgC

  23. Winner-Lab. Chagas ELISA Recombinante v 4.0. Ensayo inmunoenzimático (ELISA) para la detección de anticuerpos anti-Trypanosoma cruzi [Internet]. Argentina: Winner-Lab; 2000 [Cited 15/12/2020]. Available from: https://cutt.ly/afui27Q

  24. Ministerio de Salud y Protección Social. Resolución N° 8430 de 1993 [Internet]. Colombia: Ministerio de Salud yProtección Social; 1993 [Cited 15/12/2020]. Available from: https://cutt.ly/tfuoudZ

  25. Organización Mundial de la Salud. Declaración de Helsinki sobre Salud en Todas las Políticas. Conferencia Mundialde Promoción de la Salud [Internet]. Genova: Organización Mundial de la Salud Organización Mundial de la Salud; 2015[Cited 15/12/2020]. Available from: https://cutt.ly/Bfupqo3

  26. Suaescún S, Salamanca L, Pinazo M, Gil Ll. Sensitivity and Specificity of two rapid tests for the diagnosis of infectionby Trypanosoma cruzi in a Colombian population. Plos Neglected Tropical Disease [Internet]. 2021 [Cited 15/10/2021];48(8):2948-52. Available from: https://doi.org/10.1371/journal.pntd.0009483

  27. Cucunubá Z, Nouvellet P, Conteh L, Vera M, Angulo V, Dib J, et al. Modelling historical changes in the force-ofinfectionof Chagas disease to inform control and elimination programmes: Application in Colombia. BMJ Global Health[Internet]. 2017 [Cited 25/11/2019];2:[Aprox. 2p.]. Available from: https://cutt.ly/ffuplmk

  28. Ríos L, Crespo J, Zapata M. Ethno-Methodology to Comprehension and Management of Chagas Disease in WiwaIndigenous Communities Placed in South-Eastern Slope From Sierra Nevada de Santa Marta, Colombia . Saude eSociedade [Internet]. 2012 [Cited 22/12/2020];21(2):446-57. Available from: https://cutt.ly/ufupxF1

  29. Chappuis F, Mauris A, Holst M, Albajar P, Jannin J, Luquetti A, et al. Validation of a Rapid ImmunochromatographicAssay for Diagnosis of Trypanosoma cruzi Infection among Latin-American Migrants in Geneva, Switzerland. J ClinMicrobiol [Internet]. 2010 [Cited 25/11/2019];48(8):2948-52. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916554/

  30. Cantillo O, Medina M, Zuluaga S, Valverde C, Motta C, Ladino A, et al. Eco-epidemiological study reveals theimportance of Triatoma dimidiata in the Trypanosoma cruzi transmission, in a municipality certified withouttransmission by Rhodnius prolixus in Colombia. Acta Tropica [Internet]. 2020 [Cited 10/12/2020]; 209:105550.Available from: https://doi.org/10.1016/j.actatropica.2020.105550

  31. Cantillo O, Bedoya S, Xavier S, Zuluaga S, Salazar B, Vélez A, et al. Trypanosoma cruzi infection in domestic andsynanthropic mammals such as potential risk of sylvatic transmission in a rural area from north of Antioquia, Colombia.Parasite Epidemiology Control [Internet]. 2020 [Cited 10/01/2021]; 11(52):e00171. Available from: https://doi.org/10.1016/j.parepi.2020.e00171

  32. Parra G, Cardona A, Quirós O, Angulo V, Alexander N. House-level risk factors for Triatoma dimidiata infestation inColombia. American Journal Tropical Medicine Hygiene [Internet]. 2015 [Cited 11/11/2020];92(1):193-200. Availablefrom: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347379/

  33. Sánchez C, Albajar P, Wilkins P, Nieto J, Leiby D, Paris L, et al. Comparative Evaluation of 11 Commercialized RapidDiagnostic Tests for Detecting Trypanosoma cruzi Antibodies in Serum Banks in Areas of Endemicity and Nonendemicity.J Clin Microbiol [Internet]. 2014 [Cited 13/12/2020];52(7):2506-12 Available from: https://cutt.ly/xfupILM

  34. Ji M, Noh J, Cho B, Cho Y, Kim S, Yoon B. Evaluation of SD BIOLINE Chagas Ab Rapid kit. Korean Journal LaboratoryMedicine [Internet]. 2009 [Cited 11/12/2020]; 29(1):48-52. Available from: https://cutt.ly/OfupAoR

  35. Lorca M, Contreras M, Salinas P, Guerra A, Raychaudhuri S. Evaluación de una prueba rápida para el diagnósticode la infección por Trypanosoma cruzi en suero. Parasitol Latinoam [Internet]. 2008 [Cited 15/12/2020];63(1):29-33.Available from: https://cutt.ly/oRCsFMw

  36. Cucunubá Z, Valencia C, Puerta C, Sosa S, Torrico F, Cortés J, et al. Primer consenso colombiano sobre Chagascongénito y orientación clínica a mujeres en edad fértil con diagnóstico de Chagas. Infectio [Internet]. 2014 [Cited15/12/2020];18(2):50-65. Available from: http://dx.doi.org/10.1016/j.infect.2013.12.001

  37. Alvis N, Díaz D, Castillo L, Alvis N, Bermúdez M, Berrío O, et al. Costos de la prueba de tamización para laenfermedad de Chagas en donantes de dos bancos de sangre de Colombia, 2015. Biomedica [Internet]. 2018 [Cited11/12/2020];38(1):61-8. Available from: https://cutt.ly/CfupFkP

  38. Gonzalez L, Scollo K, Saez A, Ferlin C, Albajar P, Ciapponi A, et al. Inmunoserología y métodos molecularespara el diagnóstic de Chagas: revisión sistemática rápida. Acta Bioquím Clín Latinoam [Internet]. 2017 [Cited12/01/2021];51(1):63-74. Available from: https://cutt.ly/gzcpU2k




2020     |     www.medigraphic.com